Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bourliere

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Alimentary Pharmacology & Therapeutics|November 1, 2011
Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis CG Sebastiani, P Halfon, L Castera, et al.
Alimentary Pharmacology & Therapeutics|November 28, 2008
The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis BV Mallet, V Dhalluin-Venier, C Roussin, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2011
The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 casesG Sebastiani, L Castera, P Halfon, et al.
Liver|July 21, 2000
Absence of hepatitis C genome in semen of infected men by polymerase chain reaction, branched DNA and in situ hybridizationE Debono, P Halfon, M Bourliere, et al.
Journal of Viral Hepatitis|November 1, 1996
Myasthenia gravis and hepatitis C virus infectionP Halfon, M Levy, M San Marco, et al.
Journal of Clinical Microbiology|April 28, 2001
Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene)P Halfon, P Trimoulet, M Bourliere, et al.
Journal of Gastroenterology and Hepatology|May 1, 1992
Chlormezanone-induced fulminant hepatitis in a pregnant woman: successful delivery and liver transplantationM Bourliere, Y P Le Treut, J C Manelli, et al.
Gastroenterologie Clinique Et Biologique|June 29, 2010
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measureT Poynard, M Munteanu, Y Ngo, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatmentD C Valla, M Chevallier, P Marcellin, et al.
Journal of Viral Hepatitis|March 6, 2002
Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosisManuela G Neuman, J P Benhamou, I M Malkiewicz, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|November 1, 2011
Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis CG Sebastiani, P Halfon, L Castera, et al.
Alimentary Pharmacology & Therapeutics|November 28, 2008
The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis BV Mallet, V Dhalluin-Venier, C Roussin, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2011
The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 casesG Sebastiani, L Castera, P Halfon, et al.
Liver|July 21, 2000
Absence of hepatitis C genome in semen of infected men by polymerase chain reaction, branched DNA and in situ hybridizationE Debono, P Halfon, M Bourliere, et al.
Journal of Viral Hepatitis|November 1, 1996
Myasthenia gravis and hepatitis C virus infectionP Halfon, M Levy, M San Marco, et al.
Journal of Clinical Microbiology|April 28, 2001
Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene)P Halfon, P Trimoulet, M Bourliere, et al.
Journal of Gastroenterology and Hepatology|May 1, 1992
Chlormezanone-induced fulminant hepatitis in a pregnant woman: successful delivery and liver transplantationM Bourliere, Y P Le Treut, J C Manelli, et al.
Gastroenterologie Clinique Et Biologique|June 29, 2010
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measureT Poynard, M Munteanu, Y Ngo, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatmentD C Valla, M Chevallier, P Marcellin, et al.
Journal of Viral Hepatitis|March 6, 2002
Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosisManuela G Neuman, J P Benhamou, I M Malkiewicz, et al.
Pageof 3